Matches in SemOpenAlex for { <https://semopenalex.org/work/W1451528488> ?p ?o ?g. }
Showing items 1 to 82 of
82
with 100 items per page.
- W1451528488 endingPage "57" @default.
- W1451528488 startingPage "57" @default.
- W1451528488 abstract "Proc Amer Assoc Cancer Res, Volume 47, 2006 240 Background: Flexible Heteroarotinoids (Flex-Hets) are a novel class of compounds that induce differentiation and apoptosis in cancer cells with little effect on normal cells. SHetA2 was chosen as the lead Flex-Het, because it induced the highest levels of apoptosis in multiple cancer types. Microarray analysis identified, and RT-PCR analysis validated that expression of thymidine phosphorylase (TP) and thrombospondin 4 (TSP-4) are down-regulated by SHetA2 in ovarian cancer cell lines. Because TP and TSP-4 are involved in blood vessel formation, the ability of SHetA2 to inhibit endothelial tube formation was tested in vitro and was found to occur in a dose-dependent manner. The objectives of this study were to validate the down-regulation of TP and TSP-4 at the protein level and evaluate the anti-angiogenesis activity of SHetA2 in vivo . Methods: Ovarian cancer cell lines (A2780 and OVCAR-3) were treated with 1 or 10 μM SHetA2 for various times ranging from 30 minutes to 24 hours. Proteins were isolated and evaluated by Western blot for TP and TSP-4 expression levels. The B16 melanoma line was injected subcutaneously into syngeneic C57BL mice, which were divided into 4 treatment groups: SHetA2 gavage (12 mice) SHetA2 intratumoral (12 mice), solvent control gavage (6 mice) and solvent control intratumoral (6 mice). Mice were euthanized when tumor reached 10% body weight and tumors were fixed, embedded and sectioned. Mitoses were counted in 10 high powered fields in H&E stained sections and tumor vessels were visualized in CD34 stained sections. Results: SHetA2 inhibited TP and TSP-4 protein expression as early as 30 minutes and throughout the 24 hour evaluation period. One mouse survived in each of the SHetA2 treated groups, while none survived in the control groups. The average mitotic indices in the intratumoral and gavage control groups were 13.3 ± 1.0 and 12.1 ± 1.1, and in the SHetA2 intratumoral and gavage groups were 5.3 ± 1.6 and 3.0 ± 0.8, respectively. Control tumors had arterioles extending from a large peripheral vessel with tumor cells surrounded the arterioles. These arterioles largely disappeared in the SHetA2 treated tumors and the cancer cells were arranged into poorly formed nests that were supplied by small tenuous blood vessels. Massive necrosis was present. Discussion: These studies demonstrate that SHetA2 inhibits TP and TSP-4 protein expression in vitro , and tumor cell proliferation and angiogenesis in vivo . The inhibition of angiogenesis appears to have contributed to the inhibition of proliferation and massive necrosis in the SHetA2 treated tumors. Studies are planned to validate the functional roles of TP and TSP-4 in SHetA2 inhibition of angiogenesis. Supported by NCI grant CA106713." @default.
- W1451528488 created "2016-06-24" @default.
- W1451528488 creator A5024471347 @default.
- W1451528488 creator A5056312898 @default.
- W1451528488 creator A5059170204 @default.
- W1451528488 creator A5076769617 @default.
- W1451528488 date "2006-04-15" @default.
- W1451528488 modified "2023-09-23" @default.
- W1451528488 title "Inhibition of thymidine phosphorylase (TP), thombospondin 4 (TSP-4) and angiogenesis by flexible heteroarotinoid (Flex-Het), SHetA2" @default.
- W1451528488 hasPublicationYear "2006" @default.
- W1451528488 type Work @default.
- W1451528488 sameAs 1451528488 @default.
- W1451528488 citedByCount "0" @default.
- W1451528488 crossrefType "journal-article" @default.
- W1451528488 hasAuthorship W1451528488A5024471347 @default.
- W1451528488 hasAuthorship W1451528488A5056312898 @default.
- W1451528488 hasAuthorship W1451528488A5059170204 @default.
- W1451528488 hasAuthorship W1451528488A5076769617 @default.
- W1451528488 hasConcept C104317684 @default.
- W1451528488 hasConcept C121608353 @default.
- W1451528488 hasConcept C126322002 @default.
- W1451528488 hasConcept C150903083 @default.
- W1451528488 hasConcept C153911025 @default.
- W1451528488 hasConcept C185592680 @default.
- W1451528488 hasConcept C190283241 @default.
- W1451528488 hasConcept C207001950 @default.
- W1451528488 hasConcept C2776056115 @default.
- W1451528488 hasConcept C2776415932 @default.
- W1451528488 hasConcept C2776735402 @default.
- W1451528488 hasConcept C2780394083 @default.
- W1451528488 hasConcept C502942594 @default.
- W1451528488 hasConcept C55493867 @default.
- W1451528488 hasConcept C71924100 @default.
- W1451528488 hasConcept C86803240 @default.
- W1451528488 hasConcept C96232424 @default.
- W1451528488 hasConcept C99194444 @default.
- W1451528488 hasConceptScore W1451528488C104317684 @default.
- W1451528488 hasConceptScore W1451528488C121608353 @default.
- W1451528488 hasConceptScore W1451528488C126322002 @default.
- W1451528488 hasConceptScore W1451528488C150903083 @default.
- W1451528488 hasConceptScore W1451528488C153911025 @default.
- W1451528488 hasConceptScore W1451528488C185592680 @default.
- W1451528488 hasConceptScore W1451528488C190283241 @default.
- W1451528488 hasConceptScore W1451528488C207001950 @default.
- W1451528488 hasConceptScore W1451528488C2776056115 @default.
- W1451528488 hasConceptScore W1451528488C2776415932 @default.
- W1451528488 hasConceptScore W1451528488C2776735402 @default.
- W1451528488 hasConceptScore W1451528488C2780394083 @default.
- W1451528488 hasConceptScore W1451528488C502942594 @default.
- W1451528488 hasConceptScore W1451528488C55493867 @default.
- W1451528488 hasConceptScore W1451528488C71924100 @default.
- W1451528488 hasConceptScore W1451528488C86803240 @default.
- W1451528488 hasConceptScore W1451528488C96232424 @default.
- W1451528488 hasConceptScore W1451528488C99194444 @default.
- W1451528488 hasOpenAccess W1451528488 @default.
- W1451528488 hasRelatedWork W196519453 @default.
- W1451528488 hasRelatedWork W2013852097 @default.
- W1451528488 hasRelatedWork W2034215584 @default.
- W1451528488 hasRelatedWork W2055281446 @default.
- W1451528488 hasRelatedWork W2347572018 @default.
- W1451528488 hasRelatedWork W2353433328 @default.
- W1451528488 hasRelatedWork W2361368980 @default.
- W1451528488 hasRelatedWork W2370261261 @default.
- W1451528488 hasRelatedWork W2381650363 @default.
- W1451528488 hasRelatedWork W2387459698 @default.
- W1451528488 hasRelatedWork W2387634853 @default.
- W1451528488 hasRelatedWork W2392698671 @default.
- W1451528488 hasRelatedWork W2393495350 @default.
- W1451528488 hasRelatedWork W2518682401 @default.
- W1451528488 hasRelatedWork W2982606454 @default.
- W1451528488 hasRelatedWork W3028682169 @default.
- W1451528488 hasRelatedWork W3030874370 @default.
- W1451528488 hasRelatedWork W3030919467 @default.
- W1451528488 hasRelatedWork W3032664339 @default.
- W1451528488 hasRelatedWork W3032674880 @default.
- W1451528488 hasVolume "66" @default.
- W1451528488 isParatext "false" @default.
- W1451528488 isRetracted "false" @default.
- W1451528488 magId "1451528488" @default.
- W1451528488 workType "article" @default.